Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta-1a (IFN beta-1a) products administered intramuscularly in healthy male and female volunteers

被引:62
作者
Alam, J
Goelz, S
Rioux, P
Scaramucci, J
Jones, W
McAllister, A
Campion, M
Rogge, M
机构
[1] BIOGEN INC,PRECLIN DEV,CAMBRIDGE,MA 02142
[2] BIOGEN INC,BIOASSAY,CAMBRIDGE,MA 02142
[3] BIOGEN INC,MED AFFAIRS,CAMBRIDGE,MA 02142
[4] BIOGEN INC,CELLULAR BIOCHEM,CAMBRIDGE,MA 02142
[5] BIOGEN INC,MED AFFAIRS,F-92101 NANTERRE,FRANCE
关键词
Avonex(TM); Rebif(R); interferon-beta-1a; pharmacokinetics; pharmacodynamics;
D O I
10.1023/A:1012128406432
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
[No abstract available]
引用
收藏
页码:546 / 549
页数:4
相关论文
共 16 条
  • [1] ALAM J, 1991, Journal of Interferon Research, V11, pS246
  • [2] INTERFERON-BETA TREATMENT OF HUMAN-DISEASE
    ALAM, JJ
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 1995, 6 (06) : 688 - 691
  • [3] THE INTERFERONS - MECHANISMS OF ACTION AND CLINICAL-APPLICATIONS
    BARON, S
    TYRING, SK
    FLEISCHMANN, WR
    COPPENHAVER, DH
    NIESEL, DW
    KLIMPEL, GR
    STANTON, GJ
    HUGHES, TK
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (10): : 1375 - 1383
  • [4] A highly precise reporter gene bioassay for type I interferon
    Canosi, U
    Mascia, M
    Gazza, L
    SerlupiCrescenzi, O
    Donini, S
    Antonetti, F
    Galli, G
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 199 (01) : 69 - 76
  • [5] PHARMACOKINETICS OF RECOMBINANT HUMAN INTERFERON-BETA(SER) IN HEALTHY-VOLUNTEERS AND ITS EFFECT ON SERUM NEOPTERIN
    CHIANG, J
    GLOFF, CA
    YOSHIZAWA, CN
    WILLIAMS, GJ
    [J]. PHARMACEUTICAL RESEARCH, 1993, 10 (04) : 567 - 572
  • [6] PHARMACOKINETICS AND ANTIVIRAL ACTIVITY OF RECOMBINANT HUMAN INTERFERON-BETA(SER17) IN AFRICAN-GREEN MONKEYS
    CHIANG, J
    GLOFF, CA
    SOIKE, KF
    WILLIAMS, G
    [J]. JOURNAL OF INTERFERON RESEARCH, 1993, 13 (02): : 111 - 120
  • [7] THE ROLE OF NEOPTERIN AS A MONITOR OF CELLULAR IMMUNE ACTIVATION IN TRANSPLANTATION, INFLAMMATORY, INFECTIOUS, AND MALIGNANT DISEASES
    FUCHS, D
    WEISS, G
    REIBNEGGER, G
    WACHTER, H
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1992, 29 (3-4) : 307 - 341
  • [8] Intramuscular interferon beta-1 alpha for disease progression in relapsing multiple sclerosis
    Jacobs, LD
    Cookfair, DL
    Rudick, RA
    Herndon, RM
    Richert, JR
    Salazar, AM
    Fischer, JS
    Goodkin, DE
    Granger, CV
    Simon, JH
    Alam, JJ
    Bartoszak, DM
    Bourdette, DN
    Braiman, J
    Brownscheidle, CM
    Coats, ME
    Cohan, SL
    Dougherty, DS
    Kinkel, RP
    Mass, MK
    Munschauer, FE
    Priore, RL
    Pullicino, PM
    Scherokman, BJ
    WeinstockGuttman, B
    Whitman, RH
    Baird, WC
    Fillmore, M
    Bona, LM
    ColonRuiz, ME
    Nadine, BS
    Donovan, A
    Bennett, S
    Kieffer, YM
    Umhauer, MA
    Miller, CE
    Kilic, AK
    Sargent, EL
    Schachter, M
    Shucard, DW
    Weider, V
    Catalano, BA
    Cervi, JM
    Czekay, C
    Farrell, JL
    Filippini, JS
    Matyas, RC
    Michienzi, KE
    Ito, M
    OMalley, JA
    [J]. ANNALS OF NEUROLOGY, 1996, 39 (03) : 285 - 294
  • [9] KENWARD MG, 1989, DESIGN ANAL CROSS OV
  • [10] DOUBLE-BLIND RANDOMIZED PHASE-I STUDY ON THE CLINICAL TOLERANCE AND BIOLOGICAL EFFECTS OF NATURAL AND RECOMBINANT INTERFERON-BETA
    LIBERATI, AM
    HORISBERGER, MA
    PALMISANO, L
    ASTOLFI, S
    NASTARI, A
    MECHATI, S
    VILLA, A
    MANCINI, S
    ARZANO, S
    GRIGNANI, F
    [J]. JOURNAL OF INTERFERON RESEARCH, 1992, 12 (05): : 329 - 336